SCHEMBL19014158

SCHEMBL19014158

COC(=O)c1cc2c(C)ccc(F)c2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 8/20 0.49
TDO2 P48775 8/20 0.49
HRH4 Q9H3N8 2/20 0.45
GAA P10253 3/20 0.45
GLA P06280 1/20 0.45
XDH P47989 1/20 0.44
CYP1A2 P05177 1/20 0.41
SETD2 Q9BYW2 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
PKM P14618 2/20 0.39
TSHR P16473 2/20 0.39
ULK1 O75385 1/20 0.38
ALPL P05186 1/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8318563 0.87 GLA (0.49) HRH4GAAGLAXDHCYP1A2
SCHEMBL3276933 0.85 ALOX15 (0.47) IDO1TDO2HRH4GAAGLA
SCHEMBL20597117 0.85 IDO1 (0.49) IDO1TDO2HRH4GAAGLA
SCHEMBL30310464 0.84 IDO1 (0.48) IDO1TDO2HRH4GAAGLA
SCHEMBL18990285 0.84 IDO1 (0.48) IDO1TDO2HRH4GAAGLA
SCHEMBL22620603 0.84 XDH (0.50) IDO1TDO2HRH4GAAGLA
SCHEMBL10093729 0.83 GLA (0.46) GAAGLAXDHCYP1A2MEN1
SCHEMBL20505032 0.83 IDO1 (0.65) IDO1TDO2HRH4HPGD
SCHEMBL22620604 0.82 IDO1 (0.47) IDO1TDO2HRH4GAAGLA
SCHEMBL22620768 0.82 IDO1 (0.47) IDO1TDO2HRH4GAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106352-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-06-22 WO disclosed